Lung pathology of pale ear mouse (model of Hermansky-Pudlak syndrome 1) and beige mouse (model of Chediak-Higashi syndrome): severity of giant lamellar body degeneration of type II pneumocytes correlates with interstitial inflammation.
The authors have recently reported the presence of characteristic foamy swelling/degeneration (giant lamellar body degeneration, GLBD) of type II pneumocytes in the lungs affected by Hermansky-Pudlak syndrome (HPS)-associated interstitial pneumonia (HPSIP), and proposed the hypothesis that GLBD may be the triggering factor in the development of HPSIP (Virchows Arch 2000; 437: 304-13). The purpose of the present paper was to investigate the lung pathology of pale ear (ep) mouse, a mouse model of HPS1, and of beige (bg) mouse, a mouse model of Chediak-Higashi syndrome (CHS) with a reference to GLBD and associated pathologic changes. GLBD was found in both ep and bg mice soon after birth, and increased in severity as the mice grew older. Younger mice had only GLBD with no evidence of interstitial change. Aged bg mice showed the most prominent GLBD and patchy areas of alveolar collapse accompanied by lymphocytic infiltration and slight fibrosis. Aged ep mice with less severe GLBD than bg mice of comparable ages also had a slight tendency to develop interstitial inflammation but no fibrosis. The pneumocytes with GLBD were immunoreactive for surfactant protein B and composed of giant lamellar bodies ultrastructurally, findings which were almost identical to those of human GLBD. The results of the present study support the hypothesis that GLBD may play an important role in the development of HPSIP. Ep and bg mice, especially the latter, may be useful mouse models of HPSIP.
Tang
Xiaoyan
X
Department of Pathology, Tokyo Hospital, Tokai University School of Medicine, Tokyo, Japan. t-xiaoyan@tok.u-tokai.ac.jp
Yamanaka
Shoji
S
Miyagi
Yohei
Y
Nagashima
Yoji
Y
Nakatani
Yukio
Y
D000818:Animals; D002609:Chediak-Higashi Syndrome / Q000235:genetics / Q000473:pathology*; D003594:Cytoplasmic Granules / Q000648:ultrastructure*; D004195:Disease Models, Animal; D020022:Genetic Predisposition to Disease; D022861:Hermanski-Pudlak Syndrome / Q000235:genetics / Q000473:pathology*; D007124:Immunoenzyme Techniques; D017563:Lung Diseases, Interstitial / Q000235:genetics / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D011650:Pulmonary Alveoli / Q000473:pathology*